Previous Article | Next Article ![]()
Journal of Virology, August 2000, p. 7016-7023, Vol. 74, No. 15
Departments of Medicine and Microbiology and
Molecular Genetics, Medical College of Wisconsin, Milwaukee,
Wisconsin 53226
Received 1 March 2000/Accepted 12 May 2000
Murine gammaherpesvirus 68 (MHV68) is a gammaherpesvirus that was
first isolated from murid rodents. MHV68 establishes a latent infection in the spleen and other lymphoid organs. Several
gammaherpesviruses, including herpesvirus saimiri, human herpesvirus 8, and MHV68, encode proteins with extensive homology to the D-type
cyclins. To study the function of the cyclin homologue, a recombinant
MHV68 has been constructed that lacks the cyclin homologue and
expresses The gammaherpesviruses are an
important group of pathogens in humans and animals most notable for
their associations with tumor formation in the host and ability to
establish latent infections within lymphocytes (18, 31).
Herpesvirus saimiri (HVS) causes lymphomas in primates and can
transform T lymphocytes (19). Epstein-Barr virus (EBV) is a
significant human pathogen causing lymphomas and nasopharyngeal
carcinoma as well as transforming lymphocytes in vitro
(27; D. H. Crawford, J. A. Thomas, G. Janossy, P. Sweny, O. N. Fernando, J. F. Moorhead, and
J. H. Thompson, Letter, Lancet i:1355-1356, 1980).
Human herpesvirus 8 (HHV8) is associated with Kaposi's sarcoma, body
cavity-based lymphomas, and Castleman's disease in humans (7,
9, 39, 47; P. S. Moore and Y. Chang, Letter, Science
270:15, 1995). Mouse herpesvirus 68 (MHV68) is a
gammaherpesvirus that can serve as a model system for these viruses
(36, 40).
MHV68 was isolated from wild rodents and infects inbred and outbred
rodents (29; D. Blaskovic, M. Stancekova, J. Svobodova, and J. Mistrikova, Letter, Acta Virol. 24:468,
1980). Infection is characterized by hematogenous spread with exudative
pneumonia and splenomegaly (29, 48). MHV68 latently infects
B lymphocytes as well as other cell types (41, 45, 49, 54,
56) and has also been associated with lymphoproliferative disease
(43).
In addition to sharing biological characteristics with the other
gammaherpesviruses, there is substantial sequence homology among
the gammaherpesviruses (13, 51). Many of the
gammaherpesviruses, including HHV8, HVS, and MHV68, encode a
homologue to the D-type cyclins (2, 28, 32, 51; Y. Chang, P. S. Moore, S. J. Talbot, C. H. Boshoff, T. Zarkowska, K. Godden, H. Paterson, R. A. Weiss, and S. Mittnacht,
Letter, Nature 382:410, 1996). The notable exception is EBV,
which upregulates cellular cyclin D2 expression (3, 5, 38).
Levels of the cyclin proteins fluctuate throughout the cell cycle and
regulate cell cycle progression. The cyclin proteins function by
binding to the cyclin-dependent kinases (CDK) which phosphorylate
substrates responsible for cell cycle progression. Based on sequence
homology, the gammaherpesvirus-encoded cyclins are most similar to the
host D-type cyclins. The D-type cyclins (D1, D2, and D3) function in
G1 phase to regulate progression into S phase. The host
D-type cyclins bind to CDK 4 and 6, which phosphorylate retinoblastoma
protein releasing the E2F transcription factors which stimulate
progression into S phase (1, 26, 34, 35).
The virally encoded cyclins have been shown to share features with
cellular cyclin but have also acquired altered characteristics. Like
host D-type cyclins, HHV8 v-cyclin binds to CDK 6 and phosphorylates and inactivates retinoblastoma protein (15). MHV68-encoded
cyclin induces cell cycle progression, and transgenic mice expressing MHV68 v-cyclin produce lymphoid tumors as they age (50).
Prior to this work the role of MHV68 v-cyclin in nononcogenic
infections of MHV68 had yet to be defined. To explore its role in
various aspects of viral infection, we constructed a recombinant MHV68
lacking the cyclin D homologue (MHV68cy Viruses and tissue culture.
Our MHV68 is the same strain
used by A. Nash and coworkers (44). The complete sequence of
this virus is known (51). Virus stocks used for mouse
infections were passaged on a previously described line of rat embryo
fibroblasts (REFs) until complete cytopathic effect (CPE) was observed
(4). The titer of the wild-type virus was 2.5 × 107 PFU/ml, and the recombinant virus titer ranged between
6.0 × 106 and 2.0 × 107 PFU/ml. REF
cells were maintained in minimal essential medium (MEM) supplemented
with 10% fetal bovine serum, 30 µg of gentamicin per ml, 0.3 µg of
amphoterocin B per ml, and 2 mM L-glutamine (complete MEM).
Plasmid construct.
v-cyclin was deleted through homologous
recombination with a transfer vector as described in Fig.
1. Virion DNA from MHV68 was digested
with HindIII. The 8.35-kb fragment encoding v-cyclin (Hind D) was inserted into pSK (Stratagene, La Jolla, Calif.) lacking
an EcoRI restriction site (13). The
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Murine Gammaherpesvirus 68 Cyclin D Homologue Is
Required for Efficient Reactivation from Latency
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-galactosidase as a marker (MHV68cy
).
MHV68cy
grows in vitro with kinetics and to titers
similar to those of the wild type. BALB/c mice infected with
mixtures of equivalent amounts of the wild type and
MHV68cy
show deficient growth of the
MHV68cy
in an acute infection. Infection of SCID
mice with virus mixtures also showed decreased MHV68cy
virus growth, indicating that the deficiency is not mediated by T or B
cells. Although mice infected with mixtures containing 100 times as
much MHV68cy
had greater splenic titers of the mutant
virus than wild-type virus in acute infection, at 28 days
postinfection splenocytes from these mice reactivated primarily
wild-type virus. Quantitative PCR data indicate that equivalent genomes
were present in the latent state. Reinsertion of the cyclin homologue
into the cyclin-deleted virus restored the wild-type
phenotype. These results indicate that the MHV68 cyclin D
homologue mediates important functions in the acute infection and
is required for efficient reactivation from latency.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
). We
demonstrate here that the virus replicates efficiently in cell culture
but exhibits a deficiency in replication in acute infection in BALB/c
mice. We further show that the cyclin-deficient virus can establish
latency but very inefficiently reactivates from the latent state. We
repaired the virus by reinserting the cyclin gene and demonstrate that
the wild-type phenotype is restored (MHV68rep).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-galactosidase (
-Gal) expression cassette in pSVB (Clontech, Palo
Alto, Calif.) was excised with EcoRI and inserted into the
EcoRI site of the transfer vector, replacing a 949-bp
portion of the v-cyclin open reading frame to yield E116. The
orientation of
-Gal (Fig. 1) was determined by sequencing the fusion
between the 5' end of
-Gal and the MHV68 genome. To repair the
cyclin-deleted recombinant virus, the EcoRI restriction
fragment encoding v-cyclin was inserted in place of the
-Gal
cassette in the transfer vector to yield AH1.

View larger version (36K):
[in a new window]
FIG. 1.
Construction of recombinant MHV68cy
and
MHV68rep. (A) The cyclin-encoding EcoRI
restriction fragment was removed from the 8.35-kb
HindIII fragment (Hind D) to generate the transfer
vector used to delete v-cyclin (E116). To repair MHV68rep,
the EcoRI restriction fragment was reinserted into E116 in
place of the
-Gal cassette to generate AH1. (B) PCR amplification of
v-cyclin from MHV68cy
(cy
) was compared to
MHV68wt (wt).
Transfection and recombinant virus isolation.
Subconfluent
REFs were cotransfected with E116 (1 µg) and MHV68-infected cell DNA
by the calcium phosphate precipitation method. The repaired virus was
generated by cotransfection of AH1 and DNA from cells infected with
MHV68cy
. CPE usually occurred within 6 days
posttransfection. Supernatants from frozen and thawed cultures were
diluted and screened for
-Gal-positive virus. Recombinant virus was
isolated by limiting dilution cultures on REF cells in 96-well tissue
culture plates. Supernatant from these plates were transferred to empty
plates and frozen while the original plates were fixed and stained for
-Gal expression. Wells positive for
-Gal virus were again diluted onto 96-well plates for multiple rounds of limited dilution culture until the recombinant virus was isolated and verified by plaque assay,
PCR, restriction analysis, and Southern blotting.
was reactivating
from latency but deleting the
-Gal marker, PCR was performed as
above with a cyclin-specific primer, 5'-CCACCCAGTTGGCATACCT-3',
and a primer flanking the cyclin gene,
5'-GTAAGGGAATTCGGTAAATTC-3'.
Southern and Northern analyses of recombinant viruses.
DNA
for Southern blot analysis was extracted from infected REFs and
digested with EcoRI and HindIII.
Electrophoresis, blotting, and hybridization conditions were done by
established procedures. A nick translation system (Gibco BRL) was used
with [
-32P]ATP (Amersham, Arlington Heights, Ill.) to
label the 949-bp v-cyclin-encoding EcoRI restriction
fragment. Virion DNA was extracted and was digested with restriction
enzymes and electrophoresed on a 0.7% agarose gel for analysis
(4). Total cell RNA was extracted from infected REF cells
with TRIzol (Gibco BRL) according to manufacturer recommendations.
Northern analysis was performed according to standard procedures.
In vitro infections.
REFs or BALB/c 3T3 cells (approximately
5 × 105 per well in a six-well plate) were infected
with MHV68wt, MHV68cy
, or
MHV68rep at a multiplicity of infection (MOI) of 5 or 0.01. After a 1-h adsorption, the wells were washed with MEM. At various
times after infection, the supernatants were frozen and thawed, and the
amount of infectious virus in the supernatants was determined by plaque assay on REF cells as described below.
In vivo infections.
Female BALB/c mice (age, 4 to 6 weeks)
were obtained from Frederick Cancer Research Labs (Frederick, Md.).
Mice were inoculated intraperitoneally with virus in 1 ml of complete
MEM. At various times after infection, mice were sacrificed and assayed
for infectious virus in spleens by mincing the spleens or isolating
splenocytes as described below and sonicating in 1 ml of complete MEM
with 2 pulses of 180 W for 3 s/pulse at 4°C using the microprobe from a Branson sonicator. Sonicates were assayed on REF monolayers. After
infection for 1 h at 37°C, cells were overlaid with 0.9% methylcellulose in MEM supplemented with 5% fetal bovine serum, 25 mM
HEPES, 2 mM L-glutamine, and 30 µg of gentamicin per ml. Six days after infection, monolayers were fixed and stained with methylene blue or X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) and
plaques were counted. For X-Gal staining, cells were fixed in 2%
paraformaldehyde and 0.2% glutaraldehyde in 0.1 M
Na2PO4 for 10 min. After rinsing in
phosphate-buffered saline, plaques were stained with X-Gal (2 mg/ml) in
1.3 mM MgCl2, 3 mM K4Fe(CN)6, 3 mM
K3Fe(CN)6, and 100 mM
Na2PO4. For methylene blue staining, cells were
fixed in ethanol and then stained with 0.5% methylene blue.
Real-time PCR analysis. Quantitation of viral genomes was performed with real-time PCR using the 7700 Sequence Detection System (PE Biosystems, Foster City, Calif.). This method is based on continuous optical monitoring of a fluorogenic PCR (14, 17). In addition to the two amplification primers, an oligonucleotide homologous to the amplified region is included in the reaction mixture. The oligonucleotide is bound to a fluorescent tag that serves as a reporter and a quencher that suppresses fluorescence. During the extension phase of PCR, the 5'-to-3' exonuclease activity of Taq cleaves the reporter from the probe, releasing it from the quencher and resulting in an increase in fluorescence emission which was detected by the laser detector of the ABI Prism 7700. After crossing a sequence detection threshold, the PCR amplification results in a fluorescent signal proportional to the amount of PCR product generated. Initial template concentration is derived from the cycle number (CT) at which the fluorescent signal crosses a threshold in the exponential phase of the PCR. Standard graphs of CT values obtained from serially diluted positive controls were used to derive values for unknowns.
Three primer-probe concentrations were designed using Primer Express software (PE Biosystems). We utilized a primer and probe set specific to v-cyclin to detect MHV68wt, a set spanning the
-Gal
insertion site to detect MHV68cy
and a set specific to
the double-copy murine RNase P gene, to which viral genomes were
normalized. To generate standard curves for v-cyclin, the
EcoRI fragment encoding v-cyclin was cloned into pBluescript
SK, and for
-Gal, the previously described plasmid E116 was used.
Mouse DNA extracted from spleen cells was used to generate the standard
curve for the RNase P control. Standard curves were generated from the
CT values from serial dilutions of each
template. Copy number for infected and uninfected spleens were
calculated from the CT values of samples using
standard curves of CT values corresponding to
known copy numbers. These calculations were performed utilizing
sequence detection systems software (PE Biosystems). Each sample was
tested in duplicate, and the mean of the two values was shown as the
copy number of the sample. Calculated copy numbers were normalized to
RNase P and then adjusted to represent 1 ng of genomic DNA. Correlation
coefficients calculated by Sequence Detection Systems software were as
follows: 0.984 for cyclin, 0.996 for
-Gal, and 0.966 for RNase P.
Reactions were performed with universal master mix and universal
cycling conditions (PE Biosystems). PCR primers were synthesized by PE
Biosystems or Life Technologies, Inc. (Gaithersburg, Md). Primers were
used at a concentration of 900 nM for each primer and 200 nM of probe
in a 25-µl reaction mixture.
Primers sequences were as follows: for v-cyclin,
5'-CCTGTCAGCTACCCACGAGAG-3' and
5'-CCACCCAGTTGGCATACCT-3'; for B-Gal,
5'-CACATTCCACAGCCAAGCTGTA-3' and
5'-CAACATTCCACCTTCAACAAACA-3'; and for RNase P,
5'-GATGCCTCCCTCGCCG-3' and 5'-CTCAGCCATTGAACTCGCAC-3'.
Probe sequences were as follows: for cyclin,
VIC-TTCCAGAGTCAATAGTTTGTCAGCTGTTGTTG-TAMRA; for
-Gal, VIC-CGAGTCGAATTCTTGACTGGCCATG-TAMRA; and for RNaseP,
6FAM-AGCTTGGAACAGACTCACGGCCAGC-TAMRA.
RNA dot blot. RNA dot blot assays were performed by adding 3 volumes of denaturing solution (66% formamide, 8% formaldehyde, 0.6× MOPS [morpholinepropanesulfonic acid] buffer, pH 7.0) to 1.5 µg of RNA. The samples were heated for 15 min at 65°C followed by the addition of 2 volumes of cold 20× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Equivalent amounts of RNA were applied under vacuum (96-well minifold; Schleicher & Schuul, Inc., Keene, N.H.) to BIOTRANS nylon membrane (ICN Biomedicals Inc., East Hills, N.Y.) prewetted with 2× SSC. The filter was then washed three times with 2× SSC, baked at 80°C for 2 h, and prehybridized for 2 h at 42°C in 4 ml of RNA hybridization solution (0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin, 5× SSC, 0.1% sodium dodecyl sulfate, 50 mM sodium phosphate [pH 9.5], and 50% deionized formamide). Hybridization was carried out overnight at 42°C in 4 ml of RNA hybridization solution with the addition of 500 ng of cyclin D2 probe (a gift from C. Sherr) labeled as described previously.
| |
RESULTS |
|---|
|
|
|---|
Recombinant virus design and purification.
The v-cyclin gene
was deleted from the MHV68 genome by homologous recombination with the
E116 transfer vector shown in Fig. 1A. To generate the transfer vector
used for repair of MHV68cy
, the EcoRI
restriction fragment encoding v-cyclin was reinserted in place of the
-Gal cassette (AH1).
, E116 and DNA from cells infected with
MHV68wt were cotransfected into REFs. After CPE was
detected, viral supernatant was screened for
-Gal expression to
detect recombinant virus. The recombinant virus was then isolated from
wild-type virus by multiple rounds of limiting-dilution cultures.
When dilution cultures yielded all
-Gal-expressing virus, DNA was
extracted for analysis. PCR amplification for the cyclin gene
from REFs infected with MHV68cy
was negative for
cyclin amplification, demonstrating that the v-cyclin gene had
been deleted from the MHV68cy
genome (Fig.
1B). DNA isolated from REFs infected with purified MHV68cy
was used in a cotransfection with AH1, and
MHV68rep was isolated by limiting dilution for
-Gal-negative virus.
Analysis of recombinant viruses.
Purified
MHV68cy
and MHV68rep were analyzed by
restriction digestion (Fig.
2A), Southern
hybridization (Fig. 2B), and Northern analysis (Fig.
3C). Virion DNA was digested with
EcoRI and HindIII and was electrophoresed on
an agarose gel (Fig. 2A). No rearrangements outside of Hind D in the
MHV68cy
genome are apparent. The arrow on the right
indicates the Hind D restriction fragment that is not visible in
MHV68cy
due to the insertion of the
-Gal cassette that
adds approximately 3 kb to the size of the restriction fragment. This
is more apparent upon hybridization with the Hind D restriction
fragment (Fig. 2B). The upper panel shows the altered migration pattern
of the HindIII restriction fragment in
MHV68cy
. In the lower panel of Fig. 2B, the approximately
1-kb v-cyclin-encoding restriction fragment is absent in
MHV68cy
and present in MHV68wt and
MHV68rep. To ensure that transcription of v-cyclin from
MHV68rep was normal, and that transcription of neighboring
bcl-2 homologue has not been altered by deletion of v-cyclin, Northern
blot analysis was performed (Fig. 2C). Hybridization with v-cyclin
(upper panel) showed an identical expression pattern of two
different-sized messages from MHV68wt and
MHV68rep and no cyclin expression from
MHV68cy
. The same Northern blot was stripped and probed
with v-bcl-2. v-bcl-2 expression was similar in all samples, indicating
that its transcription was not altered in MHV68cy
and
MHV68rep.
|
|
Cyclin-deleted MHV68 grows efficiently in cell culture.
The
efficiency of replication of MHV68cy
in cell culture was
compared to MHV68wt and MHV68rep at MOIs of 5 and 0.01. In the single-step growth curve, in which cells were infected
at an MOI of 5, MHV68cy
grew with kinetics and to titers
similar to those of MHV68wt and MHV68rep in
both REF and BALB/c 3T3 cells (Fig. 3A). In the multistep growth curve,
in which cells were infected at an MOI of 0.01, MHV68cy
grew similarly to MHV68wt and MHV68rep (Fig.
3B). All three viruses replicated at about a log higher titer in REF
cells than BALB/c 3T3 cells after infection at a low MOI. However,
there was no significant difference between MHV68cy
and
MHV68wt and MHV68rep in any experiment,
indicating that v-cyclin appears to be dispensable for replication in
two cell lines.
Cyclin-deleted virus is deficient in acute infections.
The use
of MHV68 as a model system for other gammaherpesviruses allows analysis
of the phenotype of the cyclin-deleted virus in vivo. BALB/c mice were
infected with 106 PFU of MHV68wt,
MHV68cy
, and MHV68rep. Splenic titers of
virus were determined at 3, 5, and 7 days after intraperitoneal
injection. Splenocytes were disrupted by sonication to release
intracellular virus. Sonicates were then assayed on monolayers of REFs,
and plaques were stained with X-Gal 6 days after infection. Titers of
MHV68cy
drop more quickly than MHV68wt
levels, becoming undetectable by 7 days postinfection (Fig.
4A). Repair of the cyclin deletion
restores titers to those of MHV68wt, indicating that
v-cyclin is required for efficient acute infection.
|
in acute
infection in light of the efficient replication in cell culture is that the deficiency is immunologically mediated. To address this
possibility, we infected SCID mice with MHV68cy
in a
mixture of 104 PFU MHV68wt and 104
PFU MHV68cy
viruses (Fig. 4B). After 7 days, splenic
titers of MHV68cy
were 13% of titers of
MHV68wt. The titer of MHV68cy
in other organs
was consistently lower than that of MHV68wt. This provides
a qualitative assessment of the nature of the replication
deficiency, which supports the observation that MHV68cy
is deficient in acute infections and that this deficiency is inherent to the virus and is not immunologically mediated by mechanisms absent in the SCID mouse, namely T and B cells.
Cyclin-deleted virus cannot efficiently reactivate ex vivo.
We
wished to study the effect of the absence of the v-cyclin gene on
establishment and reactivation from latency. Based on analogy to
studies of latency with murine cytomegalovirus, we first needed to
establish an equivalent acute infection (30). We infected
mice with 100 times more MHV68cy
than MHV68wt
(a mixture of 5 × 106 PFU of MHV68cy
and 5 × 104 PFU of MHV68wt). Three days
postinfection there was an average of 104
PFU/106 spleen cells of MHV68cy
and 3.0 × 103 PFU of MHV68wt virus/106
spleen cells. By 5 days, the titers had dropped significantly but the
titers of MHV68cy
remained higher (Fig.
5A). We were then prepared to analyze the ability of MHV68cy
to establish and reactivate from a
latent infection.
|
and 5 × 104 PFU of MHV68wt were analyzed. Spleen cells
were plated in 10-fold dilutions of 103, 104,
and 105 cells per well. Titers of supernatants from wells
showing CPE were determined, and plaques were stained for
-Gal
expression (Fig. 5B). MHV68wt and MHV68rep
reactivate in a cell dose-response manner while reactivation of
MHV68cy
was rarely detected at any dose of spleen cells.
In four independent experiments, a total of 250 wells positive for CPE
were tested for the presence of MHV68cy
. While 99.2% of
the wells containing reactivatable virus were MHV68wt, only
2 wells (0.8%) reactivated MHV68cy
. Mice infected
separately with MHV68wt and MHV68cy
yielded
similar results (data not shown), indicating that complementation between the viruses was not occurring. Furthermore, complementation would have resulted in more reactivation of MHV68cy
,
which was not seen. To determine whether the repair of cyclin would
restore the ability of the virus to reactivate from latency, mice were
infected with 106 PFU of MHV68wt and
106 PFU of MHV68rep. Spleen cells were examined
28 days after infection, and reactivation was assessed as described
above. MHV68rep reactivated in a dose-response manner at a
similar frequency as spleen cells from mice infected with
MHV68wt (Fig. 5C).
To address the possibility that reactivating virus may represent
MHV68cy
virus that had deleted the
-Gal gene, we
amplified v-cyclin with PCR on DNA extracted from 19 pools of
reactivating virus from mice infected with 5 × 106
PFU of MHV68cy
and 5 × 104 PFU of
MHV68wt. v-cyclin was amplified from all samples tested,
but not from cells infected with MHV68cy
, indicating that
if deletion of
-Gal occurs during reactivation, it is a rare event
(data not shown). The cyclin homologue appears to be required for
efficient reactivation from latency.
Cyclin-deleted virus can establish latency.
The diminished
frequency of reactivation of MHV68cy
could be explained
by a deficiency in the establishment of latency or reactivation from
latency. To determine if latency was established equivalently by
MHV68wt and MHV68cy
under the conditions we
used to achieve equivalent acute infections, we employed a real-time
PCR method. This method employs flourescently labeled oligonucleotides
attached to a quencher that suppresses fluorescence when hybridized to
DNA. When the probe is specifically bound to the template it will be
released by the exonuclease activity associated with polymerase.
Fluorescence can then be quantitatively detected so that the intensity
of fluorescence corresponds to the quantity of template, and quantities
can be interpolated from a standard curve. To quantitate the viral
genomes we utilized a primer and probe set specific to v-cyclin to
detect MHV68wt, a set specific to the
-Gal gene to
detect MHV68cy
, and a set specific to the double-copy
murine RNase P gene, to which viral genomes can be normalized. Standard
curves were generated for v-cyclin (Fig.
6A) and
-Gal (Fig. 6B) with known
quantities of DNA. The efficiency of amplification of both templates
appears to be comparable based on the similar slope of the standard
curves. Values for unknowns were then derived from these standard
curves. Absolute viral genome copy number was normalized to that of the host genome to generate data shown in Fig. 6C as viral genomes per
nanogram of cellular DNA. PCR was performed on DNA extracted from
spleen cells from mice 28 days after infection with a mixture containing 100 times as much MHV68cy
as
MHV68wt and compared to uninfected spleen cell DNA. At 28 days postinfection, the number of MHV68wt and
MHV68cy
genomes was approximately equivalent in two
independent experiments. These numbers reflect the acute splenic
infection titer data well and predict that with increased
MHV68cy
input, MHV68cy
can efficiently
establish latency but has a defect in reactivation from latency.
|
Stimulation of cellular cyclin D2 expression cannot substitute for
the absence of MHV68 cyclin in reactivation from latency.
The
virus may encode the cellular cyclin homologue to regulate the timing
of cyclin expression. Alternatively, the function or properties of
v-cyclin may be qualitatively different than those of cellular cyclin,
as has been described for the cyclin encoded by HHV8 (15,
46). To address this question, we asked whether appropriately
timed cellular cyclin expression would stimulate MHV68cy
reactivation. Since it has been shown previously that LPS stimulates expression of cyclin D2 in B cells (47) and MHV68 latently
infects primarily B cells in the spleen (49; our
unpublished observations), we stimulated cellular cyclin D2 expression
by culturing latently infected spleen cells in the presence of LPS. A
volume of 106 spleen cells obtained 28 days postinfection
with a mixture of 5 × 106 PFU of
MHV68cy
and 5 × 104 PFU of
MHV68wt were cultured in the presence of LPS. Cellular
cyclin D2 expression was shown to increase after treatment with LPS
(Fig. 7A). After CPE was observed, the
titer of the virus from the supernatant was determined, and the plaques
were stained with X-Gal. Reactivation of MHV68cy
was
virtually absent in the presence or absence of LPS. Reactivation of
MHV68wt was not substantially influenced by LPS stimulation
of splenocytes. This provides a preliminary indication that the
function of v-cyclin cannot be substituted by appropriately timed
cellular cyclin D2 expression. It is still possible that v-cyclin can
be substituted by cyclin D1 or D3.
|
| |
DISCUSSION |
|---|
|
|
|---|
Most gammaherpesviruses, with the notable exception of EBV (which upregulates cellular cyclin) encode homologues to cyclin D (2, 28, 32, 51; Chang et al., Letter, Nature). This observation indicates that D-type cyclins may have an important role in the biology of the virus that the host cyclin D cannot provide. There are several possible roles for v-cyclin that can be envisioned. Cyclin may be important in the lytic infection by stimulating progression into S phase, which would increase expression of host proteins required for viral replication. Our data indicate clearly that in tissue culture infection this is not the case. Furthermore, data from our group and others have shown that v-cyclin is expressed with leaky-late kinetics in lytic viral replication (50). If the function of v-cyclin expression is to increase expression of proteins that function in the S phase of cell cycle to optimize viral replication, late expression would seem inappropriate unless the v-cyclin is a virion protein that acts upon entry into the cell. This raises the possibility of roles for v-cyclin in transformation or latency. Many studies have focused on the role of viral cyclins in transformation by the gammaherpesviruses (8, 12, 20, 50). MHV68 v-cyclin expressed in transgenic mice has been shown to function as an oncogene and transform lymphocytes (50). Although interesting, this observation sheds little light on the biologically relevant role of v-cyclin. Another possibility is that v-cyclin plays a role in latency. Our experiments were designed to examine which of these portions of the life cycle of MHV68 require v-cyclin.
We deleted the v-cyclin gene from MHV68 and studied the phenotype of
the mutant virus. We confirmed the deletion by PCR, restriction pattern, and Southern and Northern analyses. Expression of the neighboring bcl-2 homologue was not altered in the recombinant virus.
The recombinant virus grew efficiently in cell culture but was
deficient in replication in vivo. We infected mice with a mixture
with MHV68cy
and MHV68wt to provide a
control for each animal. This deficiency appeared to be inherent to the
virus and not immunologically mediated at least by T or B lymphocytes
since MHV68cy
replicated deficiently in the
immunologically deficient SCID mouse.
Work with murine cytomegalovirus indicated that the number of latently
infected genomes correlates with the titer of the virus in acute
infection (30). In order to create equivalent acute infections, we adjusted the input virus to 100 times more
MHV68cy
than MHV68wt. We were thus able to
establish an acute infection with MHV68cy
that was
comparable to wild-type infection. In order to investigate the role of
v-cyclin in reactivation, it was critical to establish that equivalent
latent genomes were present. We used quantitative real-time PCR to
establish that there were equivalent numbers of latent
MHV68cy
as MHV68wt genomes present in
latently infected spleen cells. Under these conditions, we observed a
dramatic deficiency in the ability of MHV68cy
to
reactivate from latency. This phenotype was corrected by repair of the
cyclin-deleted virus.
What would be the advantage to the virus to encode cyclin, when the cells it infects contain a functional cyclin? Viral cyclin may be qualitatively different from cellular cyclin. HHV8 and HVS v-cyclins preferentially bind CDK 6 and have extended substrate specificity which includes phosphorylation of a histone protein (15, 22). More recent investigations have demonstrated that HHV8- and HVS-encoded cyclins are resistant to inhibition by the CDK inhibitors, p16, p21, and p27 and that HHV8 cyclin can downregulate p27 (25, 46). Furthermore, HHV8 cyclin activates cyclin A expression in a manner that is distinct from cellular cyclin D or E (12). The usefulness of these alterations for the virus is not clear.
It is possible that MHV68-encoded cyclin may have evolved similar
qualities distinct from cellular cyclin. Other possibilities might
include an altered pattern of degradation through ubiquitination, or it
may interact with proteins which modify its function in unexpected
ways. Alternatively, the viral cyclin could be encoded by the virus so
that the virus may control the timing of expression. This might be
particularly true for reactivation if this event were to occur in
quiescent cells unprepared for DNA replication. Our observation that
the efficiency of MHV68cy
reactivation is only slightly
increased with LPS stimulation doesn't support this hypothesis, at
least with respect to cyclin D2. To address this question more
precisely, experiments are underway to place the open reading frame of
the cellular D-type cyclins under the regulatory elements of v-cyclin
in the viral genome.
The timing of cyclin expression is consistent with a role in reactivation. Results from us and others indicate that MHV68 v-cyclin is not expressed during latency and is expressed in lytic infection (37, 52). This contrasts with the expression pattern in HHV8, in which cyclin is expressed in a cell line derived from a latently infected primary effusion lymphoma (11). v-cyclin may have a different expression pattern in tumor cells than in cells in which the virus is normally latent. Genes like cyclin that have described roles in transformation may or may not have been selected in evolution for their transformative properties. If not, they have been selected for a different function in the life cycle of the virus and lead to transformation as a secondary effect or as a result of dysregulation of viral genes.
The role of cell cycle regulatory elements in herpes viral reactivation is not without precedent. Cell cycle proteins may regulate herpesvirus latency and reactivation through distinct mechanisms. The alphaherpesvirus bovine herpesvirus expresses a single RNA during latency, the latency-related gene product. This RNA has been shown to bind to cyclin A and prevent cell cycle progression (33). In HSV, the immediate-early protein Vmw110 is required for efficient reactivation from latency and has also been shown to inhibit progression of transfected cells though mitosis and at the G1/S phase border (16, 24, 57). Apparently paradoxically, it has also been shown to stabilize a D-type cyclin (21). The EBV-encoded gene product Zta, which contributes to the switch from latent to lytic gene expression, inhibits cell cycle progression prior to S phase (6, 10, 23). The apparent discrepancy in the stimulation and arrest of cell cycle could be explained in many cases by the possibility that genes expressed late in G1 could be important for viral replication and reactivation. In any case, cell cycle positioning is an important element in regulating latency and reactivation from latency.
If latency is to have any value as a survival strategy the viral genome must persist intact so that at some later time a productive acute infection can the initiated. Gene products in EBV and HHV8 that trigger reactivation have been identified by utilizing latently infected cell lines (10, 42). While latently infected cell lines are useful for identification of proteins that trigger reactivation, they allow limited conclusions to be made about the role of these proteins in vivo. The observation that cyclin is required for reactivation in MHV68 will allow further investigation into the mechanism of reactivation of the gammaherpesviruses in vivo.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. Headrick and M. Stanley for excellent technical assistance and helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Departments of Medicine and Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI 53226. Phone: (414) 456-4989. Fax: (414) 456-6533. E-mail: wburns{at}mcw.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ajchenbaum, F.,
K. Ando,
J. A. DeCaprio, and J. D. Griffin.
1993.
Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
J. Biol. Chem.
268:4113-4119 |
| 2. |
Albrecht, J. C.,
J. Nicholas,
D. Biller,
K. R. Cameron,
B. Biesinger,
C. Newman,
S. Wittmann,
M. A. Craxton,
H. Coleman, and B. Fleckenstein.
1992.
Primary structure of the herpesvirus saimiri genome.
J. Virol.
66:5047-5058 |
| 3. | Arvanitakis, L., N. Yaseen, and S. Sharma. 1995. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J. Immunol. 155:1047-1056[Abstract]. |
| 4. | Burns, W. H., G. M. Barbour, and G. R. Sandford. 1988. Molecular cloning and mapping of rat cytomegalovirus DNA. Virology 166:140-148[CrossRef][Medline]. |
| 5. | Cannell, E. J., P. J. Farrell, and A. J. Sinclair. 1996. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene 13:1413-1421[Medline]. |
| 6. | Cayrol, C., and E. K. Flemington. 1996. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:2748-2759[Medline]. |
| 7. |
Cesarman, E.,
Y. Chang,
P. S. Moore,
J. W. Said, and D. M. Knowles.
1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.
N. Engl. J. Med.
332:1186-1191 |
| 8. | Cesarman, E., R. G. Nador, F. Bai, R. A. Bohenzky, J. J. Russo, P. S. Moore, Y. Chang, and D. M. Knowles. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-8223[Abstract]. |
| 9. |
Chang, Y.,
E. Cesarman,
M. S. Pessin,
F. Lee,
J. Culpepper,
D. M. Knowles, and P. S. Moore.
1994.
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science
266:1865-1869 |
| 10. |
Countryman, J.,
H. Jenson,
R. Seibl,
H. Wolf, and G. Miller.
1987.
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
J. Virol.
61:3672-3679 |
| 11. |
Dittmer, D.,
M. Lagunoff,
R. Renne,
K. Staskus,
A. Haase, and D. Ganem.
1998.
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.
J. Virol.
72:8309-8315 |
| 12. | Duro, D., A. Schulze, B. Vogt, J. Bartek, S. Mittnacht, and P. Jansen-Durr. 1999. Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8. J. Gen. Virol. 80:549-555[Abstract]. |
| 13. |
Efstathiou, S.,
Y. M. Ho, and A. C. Minson.
1990.
Cloning and molecular characterization of the murine herpesvirus 68 genome.
J. Gen. Virol.
71:1355-1364 |
| 14. |
Gibson, U. E.,
C. A. Heid, and P. M. Williams.
1996.
A novel method for real time quantitative RT-PCR.
Genome Res.
6:995-1001 |
| 15. | Godden-Kent, D., S. J. Talbot, C. Boshoff, Y. Chang, P. Moore, R. A. Weiss, and S. Mittnacht. 1997. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71:4193-4198[Abstract]. |
| 16. |
Harris, R. A.,
R. D. Everett,
X. X. Zhu,
S. Silverstein, and C. M. Preston.
1989.
Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system.
J. Virol.
63:3513-3515 |
| 17. |
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986-994 |
| 18. |
Honess, R. W.
1984.
Herpes simplex and `the herpes complex': diverse observations and a unifying hypothesis. The eighth Fleming lecture.
J. Gen. Virol.
65:2077-2107 |
| 19. | Jung, J. U., J. K. Choi, A. Ensser, and B. Biesinger. 1999. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin. Cancer Biol. 9:231-239[CrossRef][Medline]. |
| 20. |
Jung, J. U.,
M. Stager, and R. C. Desrosiers.
1994.
Virus-encoded cyclin.
Mol. Cell. Biol.
14:7235-7244 |
| 21. | Kawaguchi, Y., C. Van Sant, and B. Roizman. 1997. Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71:7328-7336[Abstract]. |
| 22. | Li, M., H. Lee, D. W. Yoon, J. C. Albrecht, B. Fleckenstein, F. Neipel, and J. U. Jung. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71:1984-1991[Abstract]. |
| 23. |
Lieberman, P. M.,
J. M. Hardwick,
J. Sample,
G. S. Hayward, and S. D. Hayward.
1990.
The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
J. Virol.
64:1143-1155 |
| 24. |
Lomonte, P., and R. D. Everett.
1999.
Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle.
J. Virol.
73:9456-9467 |
| 25. | Mann, D. J., E. S. Child, C. Swanton, H. Laman, and N. Jones. 1999. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18:654-663[CrossRef][Medline]. |
| 26. | Matsushime, H., M. F. Roussel, and C. J. Sherr. 1991. Novel mammalian cyclins (CYL genes) expressed during G1. Cold Spring Harbor Symp. Quant. Biol. 56:69-74[Medline]. |
| 27. | Miller, G. 1990. Epstein-Barr virus: biology, pathogenesis, and medical aspects, p. 1921-1958. In B. N. Fields, and D. M. Knipe (ed.), Fields virology, vol. 2. Raven Press, Ltd., New York, N.Y. |
| 28. | Nicholas, J., K. R. Cameron, and R. W. Honess. 1992. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355:362-365[CrossRef][Medline]. |
| 29. | Rajcani, J., D. Blaskovic, J. Svobodova, F. Ciampor, D. Huckova, and D. Stanekova. 1985. Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol. 29:51-60[Medline]. |
| 30. |
Reddehase, M. J.,
M. Balthesen,
M. Rapp,
S. Jonjic,
I. Pavic, and U. H. Koszinowski.
1994.
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
J. Exp. Med.
179:185-193 |
| 31. | Roizman, B., L. E. Carmichael, F. Deinhardt, G. de The, A. J. Nahmias, W. Plowright, F. Rapp, P. Sheldrick, M. Takahashi, and K. Wolf. 1981. Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. Intervirology 16:201-217[Medline]. |
| 32. |
Russo, J. J.,
R. A. Bohenzky,
M. C. Chien,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
Y. Chang, and P. S. Moore.
1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867 |
| 33. | Schang, L. M., A. Hossain, and C. Jones. 1996. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J. Virol. 70:3807-3814[Abstract]. |
| 34. | Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187-190[CrossRef][Medline]. |
| 35. | Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065[Medline]. |
| 36. | Simas, J. P., and S. Efstathiou. 1998. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 6:276-282[CrossRef][Medline]. |
| 37. | Simas, J. P., D. Swann, R. Bowden, and S. Efstathiou. 1999. Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J. Gen. Virol. 80:75-82[Abstract]. |
| 38. | Sinclair, A. J., I. Palmero, A. Holder, G. Peters, and P. J. Farrell. 1995. Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene. J. Virol. 69:1292-1295[Abstract]. |
| 39. |
Soulier, J.,
L. Grollet,
E. Oksenhendler,
P. Cacoub,
D. Cazals-Hatem,
P. Babinet,
M. F. d'Agay,
J. P. Clauvel,
M. Raphael, and L. Degos.
1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Blood
86:1276-1280 |
| 40. | Speck, S. H., and H. W. Virgin. 1999. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr. Opin. Microbiol. 2:403-409[CrossRef][Medline]. |
| 41. |
Stewart, J. P.,
E. J. Usherwood,
A. Ross,
H. Dyson, and T. Nash.
1998.
Lung epithelial cells are a major site of murine gammaherpesvirus persistence.
J. Exp. Med.
187:1941-1951 |
| 42. |
Sun, R.,
S. F. Lin,
L. Gradoville,
Y. Yuan,
F. Zhu, and G. Miller.
1998.
A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.
Proc. Natl. Acad. Sci. USA
95:10866-10871 |
| 43. | Sunil-Chandra, N. P., J. Arno, J. Fazakerley, and A. A. Nash. 1994. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145:818-826[Abstract]. |
| 44. |
Sunil-Chandra, N. P.,
S. Efstathiou,
J. Arno, and A. A. Nash.
1992.
Virological and pathological features of mice infected with murine gamma-herpesvirus 68.
J. Gen. Virol.
73:2347-2356 |
| 45. |
Sunil-Chandra, N. P.,
S. Efstathiou, and A. A. Nash.
1992.
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.
J. Gen. Virol.
73:3275-3279 |
| 46. | Swanton, C., D. J. Mann, B. Fleckenstein, F. Neipel, G. Peters, and N. Jones. 1997. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390:184-187[CrossRef][Medline]. |
| 47. | Tanguay, D. A., and T. C. Chiles. 1996. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539-548[Abstract]. |
| 48. |
Usherwood, E. J.,
A. J. Ross,
D. J. Allen, and A. A. Nash.
1996.
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells.
J. Gen. Virol.
77:627-630 |
| 49. |
Usherwood, E. J.,
J. P. Stewart,
K. Robertson,
D. J. Allen, and A. A. Nash.
1996.
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
J. Gen. Virol.
77:2819-2825 |
| 50. |
van Dyk, L. F.,
J. L. Hess,
J. D. Katz,
M. Jacoby,
S. H. Speck, and H. W. Virgin, IV.
1999.
The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.
J. Virol.
73:5110-5122 |
| 51. | Virgin, H. W., P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904[Abstract]. |
| 52. |
Virgin, H. W.,
R. M. Presti,
X. Y. Li,
C. Liu, and S. H. Speck.
1999.
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.
J. Virol.
73:2321-2332 |
| 53. | Virgin, H. W., and S. H. Speck. 1999. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-379[CrossRef][Medline]. |
| 54. |
Weck, K. E.,
M. L. Barkon,
L. I. Yoo,
S. H. Speck, and H. W. Virgin, IV.
1996.
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.
J. Virol.
70:6775-6780 |
| 55. |
Weck, K. E.,
S. S. Kim,
H. W. Virgin IV, and S. H. Speck.
1999.
B cells regulate murine gammaherpesvirus 68 latency.
J. Virol.
73:4651-4661 |
| 56. |
Weck, K. E.,
S. S. Kim,
H. W. Virgin, IV, and S. H. Speck.
1999.
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells.
J. Virol.
73:3273-3283 |
| 57. |
Zhu, X. X.,
J. X. Chen,
C. S. Young, and S. Silverstein.
1990.
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products.
J. Virol.
64:4489-4498 |
This article has been cited by other articles: